3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Wilms Tumor
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Hepatoblastoma
1
Carcinoma, Renal Cell
1
Interventions
Cyclophosphamide
7
pembrolizumab
6
Radiosurgery
6
Specimen Handling
5
Nivolumab
5
Ifosfamide
5
fludarabine phosphate
4
Mycophenolic Acid
4
Granulocyte Colony-Stimulating Factor
4
Etoposide
4
Busulfan
4
Sunitinib
3
Sirolimus
3
Radiotherapy
3
Peripheral Blood Stem Cell Transplantation
3
Paclitaxel
3
Melphalan
3
Magnetic Resonance Spectroscopy
3
Filgrastim
3
Cyclosporine
3
Cryosurgery
3
Carboplatin
3
trastuzumab deruxtecan
2
tislelizumab
2
sargramostim
2
pazopanib
2
fludarabine
2
etoposide phosphate
2
cabozantinib
2
Whole-Body Irradiation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
Simvastatin
×
Sarcoma
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled